ProQR Therapeutics
PRQR
PRQR
55 hedge funds and large institutions have $215M invested in ProQR Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less capital invested
Capital invested by funds: $340M → $215M (-$125M)
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.25M | |
| 2 | +$3.66M | |
| 3 | +$2.55M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.54M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$2.39M |
Top Sellers
| 1 | -$10M | |
| 2 | -$5.46M | |
| 3 | -$4.02M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.63M |
| 5 |
Goldman Sachs
New York
|
-$1.7M |